Portrazza Necitumumab 800mg/50ml


Portrazza is a prescription drug used for the treatment of patients with metastatic squamous non-small cell lung cancer. It is a monoclonal antibody that blocks a certain protein in the body to protect the healthy cells from damage. To buy Portrazza 800mg/50ml or to know its price contact 3S Corporation.

Manufacturer : Eli Lilly and Company


Strengths available :  800mg/50ml

Form :  Injection

Dosage : Usual Adult Dose for Non-Small Cell Lung Cancer: 800 mg IV over 60 minutes on Days 1 and 8 of each 3-week cycle prior to gemcitabine and cisplatin infusion.

Duration of therapy: Continue until disease progression or unacceptable toxicity.

Storage : Store at 2°C to 8°C

Is the medicine FDA  approved : Yes

Date of Approval : November 24, 2015


Common side effects are vomiting, diarrhea, skin rash or low levels of magnesium in your blood.


Pack of 1 vial


There are no reviews yet.

Be the first to review “Portrazza Necitumumab 800mg/50ml”

Your email address will not be published. Required fields are marked *